Market Currents
Forbes contributor Igor Greenwald castigates Bill Ackman for shorting Herbalife (HLF -1.4%),...
-
Thursday, December 20, 2012, 9:33 AM ETForbes contributor Igor Greenwald castigates Bill Ackman for shorting Herbalife (HLF -1.4%), accusing him (and David Einhorn) of possible "Look at Me!" self-promotion to "induce a desired result simply by attaching their name to it." Greenwald wants Ackman to "explain how a 'pyramid scheme' lasts 32 years without an army of disabused and dispossessed latecomers ... clamoring for refunds," not to mention HLF's stellar financial performance. (Ackman is giving his reasoning now at the Ira Sohn conference in NYC.)
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 13 comments:
However, is it possible for a pyramid scheme to last 32 years with no dissatisfied participants? Yes, just ask Bernard Made-off.
HLF going to $34 as suggested on May 3, 2012 (found here: http://seekingalpha.co...).
Regards.
So Ackman has something to hang his hat on.
Ackman when he is short is very vocal, witness his conduct while short MBIA. I don't like his style but suspect he is within the law on HLF.
Under a 100 comments, no vested interest or credibility.
Regards.
Based on what I heard, there was not a single new charge against HLF that we haven't heard before.
That makes ... sense... ???
Maybe you should check out his other positions and his performance before you say something IDIOTIC
.
Obviously not guaranteed, however, all indications are that $24 is the next downside target to watch for.
Regards.
Will be interesting to see how this develops
Cheers
Thanks for the comment. On our site we posted an update on our HLF targets (found here: http://bit.ly/ZHISBH), this time with upside targets. We said the following:
"At the current price of $27.27, HLF has fallen below the ascending extreme downside target of $24.33. This suggests that a $24.33 handle on this stock is almost guaranteed on an intra-day basis, at minimum.
"After reaching the inevitable low in the current decline, we expect HLF to increase at least +30%."
We're probably lucky in our analysis, however we're testing Edson Gould's SRLs and have some interesting, albeit lucky, examples of success. We promptly bought HLF on a speculative basis after the stock hit the $24.50 level.
Now we're REALLY interested in seeing how this develops.
Regards.